DENTSPLY SIRONA Inc

XRAY

Equity

ISIN null / Valor 31773200

NASDAQ (2026-07-02)

USD 11.65+5.05%

DENTSPLY SIRONA Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

DENTSPLY SIRONA Inc is a global leader in the manufacturing of professional dental products and technologies, working in collaboration with partners to develop innovative solutions for dental professionals worldwide. With a mission to transform dentistry and improve oral health on a global scale, the company is dedicated to empowering dental practices, clinics, laboratories, and distributors to deliver top-quality dental care to patients. DENTSPLY SIRONA's research division plays a key role in driving the development of next-generation dental solutions, reflecting the company's commitment to advancing the field of dentistry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-29.7%1Y

-70.9%3Y

-81.8%5Y

Performance

43.7%1Y

41.4%3Y

38.2%5Y

Volatility

2334 M

Market cap (USD)

4,797,010

Daily traded volume (Shares)

18.86 / 18.36

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.00

1 votes

Performance:

2.00

Innovation:

4.00

Society:

3.00

Nature:

3.00

Matthew Tombaugh

Switzerland, 23 Mar 2026

A textbook deep value play. The stock is priced for failure at 8.9x earnings, but management is at the 10-yard line of a turnaround. Cutting the dividend to buy back shares at these depressed levels is a aggressive, shareholder-friendly move.

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc